Literature DB >> 14599716

Expression and localization of AT1 receptors in hepatic Kupffer cells: its potential role in regulating a fibrogenic response.

Po Sing Leung1, Po Man Suen, Siu Po Ip, Chun Kit Yip, George Chen, Paul B S Lai.   

Abstract

Previous studies have showed that the renin-angiotensin system (RAS) plays an important role in the pathogenesis of liver cirrhosis. The localization of angiotensin II receptor in hepatic stellate cells opens up a new research direction of RAS in the regulation of liver fibrosis. However, the potential role of angiotensin II on Kupffer cells remains unexplored. As Kupffer cells are actively involved in the fibrotic process, the present study aimed, specifically, to demonstrate the presence of key RAS components, with particular reference to the AT(1) receptor, and its potential role in hepatic Kupffer cells. The expression of key RAS components in rat liver and isolated hepatic Kupffer cells was analyzed by RT-PCR. The expression and precise localization of AT(1) receptors in hepatic Kupffer cells were investigated by Western blot analysis and immunofluorescent double staining, respectively. The effect of angiotensin-stimulated Kupffer cells on the expression of the fibrogenic factors, i.e. transforming growth factor-beta (TGF-beta) and fibronectin, was examined by semi-quantitative RT-PCR. RT-PCR analysis showed that mRNA of several key RAS components-angiotensin II receptors, angiotensinogen, renin and angiotensin-converting enzyme, particularly the AT(1) receptors, was expressed in the liver and isolated hepatic Kupffer cells. The AT(1) receptor protein was consistently expressed in hepatic Kupffer cells as evidenced by Western blot analysis. Double immunostaining confirmed that the AT(1) receptors were specifically localized to the Kupffer cells from the liver and isolated hepatic Kupffer cells. On the other hand, angiotensin II stimulated mRNA expression of TGF-beta and fibronectin, which could be inhibitable by saralasin and losartan, the nonselective and specific antagonists for AT(1) receptors, respectively. The present findings clearly demonstrated the expression, localization and potential role of local RAS components with particular emphasis on the AT(1) receptors in hepatic Kupffer cells. The intimate interaction of angiotensin II with its AT(1) receptor located in the Kupffer cells and its fibrogenic action may represent a regulatory mechanism in the development of liver fibrosis such as inflammation and cirrhosis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14599716     DOI: 10.1016/s0167-0115(03)00192-7

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  21 in total

1.  Effects of six months losartan administration on liver fibrosis in chronic hepatitis C patients: a pilot study.

Authors:  Silvia Sookoian; María Alejandra Fernández; Gustavo Castaño
Journal:  World J Gastroenterol       Date:  2005-12-28       Impact factor: 5.742

Review 2.  Nonalcoholic fatty liver disease: diagnosis and relation to metabolic syndrome and approach to treatment.

Authors:  Steven D Lidofsky
Journal:  Curr Diab Rep       Date:  2008-02       Impact factor: 4.810

3.  Losartan may inhibit the progression of liver fibrosis in chronic HCV patients.

Authors:  Zakaria A Salama; Ahmed Sadek; Ahmed M Abdelhady; Samar Kamal Darweesh; Shereif Ahmed Morsy; Gamal Esmat
Journal:  Hepatobiliary Surg Nutr       Date:  2016-06       Impact factor: 7.293

Review 4.  The world pandemic of vitamin D deficiency could possibly be explained by cellular inflammatory response activity induced by the renin-angiotensin system.

Authors:  Marcelo Ferder; Felipe Inserra; Walter Manucha; León Ferder
Journal:  Am J Physiol Cell Physiol       Date:  2013-01-30       Impact factor: 4.249

5.  The renin angiotensin system regulates Kupffer cells in colorectal liver metastases.

Authors:  Shu Wen Wen; Eleanor I Ager; Jaclyn Neo; Christopher Christophi
Journal:  Cancer Biol Ther       Date:  2013-06-17       Impact factor: 4.742

6.  Directly acting drugs prostacyclin or nitroglycerine and endothelin receptor blocker bosentan improve cell engraftment in rodent liver.

Authors:  Ralf Bahde; Sorabh Kapoor; Sriram Bandi; Kuldeep K Bhargava; Christopher J Palestro; Sanjeev Gupta
Journal:  Hepatology       Date:  2013-01       Impact factor: 17.425

7.  Effect of losartan, an angiotensin II antagonist, on hepatic fibrosis induced by CCl4 in rats.

Authors:  Yao Hong Wei; Li Jun; Chen Ji Qiang
Journal:  Dig Dis Sci       Date:  2004-10       Impact factor: 3.199

8.  Changes in the renin angiotensin system during the development of colorectal cancer liver metastases.

Authors:  Jaclyn H Neo; Eleanor I Ager; Peter W Angus; Jin Zhu; Chandana B Herath; Christopher Christophi
Journal:  BMC Cancer       Date:  2010-04-10       Impact factor: 4.430

Review 9.  Renin angiotensin system and its role in biomarkers and treatment in gliomas.

Authors:  Alexander Perdomo-Pantoja; Sonia Iliana Mejía-Pérez; Liliana Gómez-Flores-Ramos; Montserrat Lara-Velazquez; Cordelia Orillac; Juan Luis Gómez-Amador; Talia Wegman-Ostrosky
Journal:  J Neurooncol       Date:  2018-02-16       Impact factor: 4.130

10.  Sex-related influence of angiotensin-converting enzyme polymorphisms on fibrosis progression due to recurrent hepatitis C after liver transplantation.

Authors:  Carlo Fabris; Pierluigi Toniutto; Davide Bitetto; Rosalba Minisini; Ezio Fornasiere; Carlo Smirne; Mario Pirisi
Journal:  J Gastroenterol       Date:  2007-07-25       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.